Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.

Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, Kim M, Kang KS, Daley GQ, Brundin P, Song J.

Stem Cells. 2012 Sep;30(9):2054-62. doi: 10.1002/stem.1135. Erratum in: Stem Cells. 2012 Nov;30(11):2602.

2.

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.

Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.

3.

In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease.

Jeon I, Choi C, Lee N, Im W, Kim M, Oh SH, Park IH, Kim HS, Song J.

Int J Stem Cells. 2014 May;7(1):43-7. doi: 10.15283/ijsc.2014.7.1.43.

4.

Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.

Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, Shin DA, Lee DR, Do JT, Park IH, Daley GQ, Song J.

Biochem J. 2012 Sep 15;446(3):359-71. doi: 10.1042/BJ20111495.

PMID:
22694310
5.
6.

Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease.

Bosch M, Pineda JR, Suñol C, Petriz J, Cattaneo E, Alberch J, Canals JM.

Exp Neurol. 2004 Nov;190(1):42-58.

PMID:
15473979
7.

Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM.

Cell Stem Cell. 2012 Aug 3;11(2):253-63. doi: 10.1016/j.stem.2012.04.026. Epub 2012 Jun 28.

8.

Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.

Fink KD, Crane AT, Lévêque X, Dues DJ, Huffman LD, Moore AC, Story DT, Dejonge RE, Antcliff A, Starski PA, Lu M, Lescaudron L, Rossignol J, Dunbar GL.

Stem Cells Transl Med. 2014 May;3(5):620-31. doi: 10.5966/sctm.2013-0151. Epub 2014 Mar 21.

9.

Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.

Choi KA, Hwang I, Park HS, Oh SI, Kang S, Hong S.

Biotechnol J. 2014 Jul;9(7):882-94. doi: 10.1002/biot.201300560. Epub 2014 May 15. Review.

PMID:
24827816
10.

Modeling Huntington's disease with induced pluripotent stem cells.

Kaye JA, Finkbeiner S.

Mol Cell Neurosci. 2013 Sep;56:50-64. doi: 10.1016/j.mcn.2013.02.005. Epub 2013 Feb 28. Review.

11.

Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.

Mu S, Wang J, Zhou G, Peng W, He Z, Zhao Z, Mo C, Qu J, Zhang J.

PLoS One. 2014 Jul 23;9(7):e101185. doi: 10.1371/journal.pone.0101185. eCollection 2014.

12.

Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease.

Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Björklund A, Emerich DF, Hammang J, Carpenter MK.

J Comp Neurol. 1997 Oct 13;387(1):96-113.

PMID:
9331174
13.

Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.

Mazurová Y, Gunčová I, Látr I, Rudolf E.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):486-99. Review.

PMID:
21495959
14.

Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

HD iPSC Consortium.

Cell Stem Cell. 2012 Aug 3;11(2):264-78. doi: 10.1016/j.stem.2012.04.027. Epub 2012 Jun 28.

15.

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.

Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLarnon JG, Kim SU.

Neurobiol Dis. 2004 Jun;16(1):68-77.

PMID:
15207263
16.

Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.

Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, Bokla L, Landwehrmeyer GB, Volk B, Nikkhah G.

Neuroscience. 2009 May 19;160(3):661-75. doi: 10.1016/j.neuroscience.2009.02.035. Epub 2009 Feb 28.

PMID:
19254752
17.

Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions.

Song J, Lee ST, Kang W, Park JE, Chu K, Lee SE, Hwang T, Chung H, Kim M.

Neurosci Lett. 2007 Aug 9;423(1):58-61. Epub 2007 Jul 14.

PMID:
17669593
18.

Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease.

Vazey EM, Dottori M, Jamshidi P, Tomas D, Pera MF, Horne M, Connor B.

Cell Transplant. 2010;19(8):1055-62. doi: 10.3727/096368910X494632. Epub 2010 Mar 26.

PMID:
20350346
19.
20.

Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain.

Oki K, Tatarishvili J, Wood J, Koch P, Wattananit S, Mine Y, Monni E, Tornero D, Ahlenius H, Ladewig J, Brüstle O, Lindvall O, Kokaia Z.

Stem Cells. 2012 Jun;30(6):1120-33. doi: 10.1002/stem.1104.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk